Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)

BACKGROUND: Idiopathic nephrotic syndrome (INS) is the most common chronic glomerular disease in children. Approximately 80–90% of patients with childhood INS have steroid-sensitive nephrotic syndrome (SSNS), and can obtain remission with steroid therapy, while the remainder have steroid-resistant n...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Nephrol
Päätekijät: Horinouchi, Tomoko, Sako, Mayumi, Nakanishi, Koichi, Ishikura, Kenji, Ito, Shuichi, Nakamura, Hidefumi, Oba, Mari Saito, Nozu, Kandai, Iijima, Kazumoto
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6211590/
https://ncbi.nlm.nih.gov/pubmed/30382824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-1099-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia